Evidence of Recent Progress in Clinical Practice and Research in Infectious Disease without Official Measures or Meddling – An Example for Germany* W. Marget Editorial Pages: 305 - 306
Dutch Guideline for Preventing Nosocomial Transmission of Highly Resistant Microorganisms (HRMO) M. F. Q. Kluytmans–VandenBerghJ. A. J. W. KluytmansA. Voss Review Pages: 309 - 313
Low Rate of Clinical Consequences Derived from Results of Blood Cultures Obtained in an Internal Medicine Emergency Department B. P. EhrensteinT. JarryT. Glück Clinical and Epidemiological Study Pages: 314 - 319
Antibiotic-Resistant Bloodstream Infections in Hospitalized Patients: Specific Risk Factors in a High–Risk Population? Heike von BaumJ. F. OberM. B. Edmond Clinical and Epidemiological Study Pages: 320 - 326
Risk Factors for Colonization with Third–Generation Cephalosporin–Resistant Enterobacteriaceae C. WendtD. LinH. von Baum Clinical and Epidemiological Study Pages: 327 - 332
Antibiotic Use in Non–University Regional Acute Care General Hospitals in Southwestern Germany, 2001–2002 W. V. KernKatja de Withand the MABUSE–INTERREGIO–II Project Team* Clinical and Epidemiological Study Pages: 333 - 339
Prevalence of Clostridium difficile Toxins A and B and Clostridium perfringens Enterotoxin A in Stool Samples of Patients with Antibiotic–Associated Diarrhea M. M. HeimesaatK. GranzowO. Liesenfeld Clinical and Epidemiological Study Pages: 340 - 344
Incidence and Prognosis of CMV Disease in HIV–Infected Patients before and after Introduction of Combination Antiretroviral Therapy B. SalzbergerP. HartmannG. Fätkenheuer Clinical and Epidemiological Study Pages: 345 - 349
Prospective Surveillance of Nosocomial Infections in a Swiss NICU: Low Risk of Pneumonia on Nasal Continuous Positive Airway Pressure? J. HentschelB. BrünggerK. Mühlemann Clinical and Epidemiological Study Pages: 350 - 355
Pseudomonas aeruginosa Strains from Nosocomial Pneumonia Are More Serum Resistant than P. aeruginosa Strains from Noninfectious Respiratory Colonization Processes A. VitkauskieneS. ScheußH. Sahly Clinical and Epidemiological Study Pages: 356 - 361
Silencing of Bak Ameliorates Apoptosis of Human Proximal Tubular Epithelial Cells by Escherichia coli–Derived Shiga Toxin 2 C. WilsonG. H. FosterM. Bitzan Experimental Study Pages: 362 - 367
Inducible Metronidazole Resistance in nim–Positive and nim–Negative Bacteroides fragilis Group Strains after Several Passages Metronidazole Containing Columbia Agar Plates R. SchaumannS. PetzoldA. C. Rodloff Brief Report Pages: 368 - 372
Analysis of the Specific Immune Response against Capsular Polysaccharides of Two Patients with Systemic Enterococcal Infections M. HufnagelJ. Huebner Brief Report Pages: 373 - 376
In vitro Assessment of the Host Response against Enterococcus faecalis Used in Probiotic Preparations A. KropecM. HufnagelJ. Huebner Brief Report Pages: 377 - 379
Interleukin–8 Serum Levels at Fever Onset in Patients with Neutropenia Predict Early Medical Complications A. EngelStefanie KnollW. V. Kern Brief Report Pages: 380 - 382
Fatal Outcome of a Hyperinfection Syndrome despite Successful Eradication of Strongyloides with Subcutaneous Ivermectin H. P. HauberJ. GalleC. Lange Case Report Pages: 383 - 386
Aortitis Diagnosed by F–18–Fluorodeoxyglucose Positron Emission Tomography in a Patient with Syphilis and HIV Coinfection K. KöstersC. P. Bleeker–RoversA. J. A. M. van der Ven Case Report Pages: 387 - 389
Peritonitis Due to Neisseria mucosa in an Adolescent Receiving Peritoneal Dialysis A. K. ShettyS. K. NagarajM. Bitzan Case Report Pages: 390 - 392
Landouzy Septicemia (Sepsis Tuberculosa Acutissima) Due to Mycobacterium microti in an Immunocompetent Man H. K. GeissRita FeldhuesR. Rieker Case Report Pages: 393 - 396
Breakthrough Invasive Infection Due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a Stem Cell Transplant Patient Receiving Liposomal Amphotericin B and Caspofungin for Suspected Aspergillosis D. WagnerAnna SanderW. V. Kern Case Report Pages: 397 - 400
What's New in HIV/AIDS? Neutralizing HIV Antibodies: Do they Really Protect? B. JülgF. D. Goebel HIV/AIDS Pages: 405 - 407
What’s New in HIV/AIDS? Chemokine Receptor Antagonists: A New Era of HIV Therapy? B. JülgF. D. Goebel HIV/AIDS Pages: 408 - 410